Viral load of human herpesvirus 8 in peripheral blood of human immunodeficiency virus-infected patients with Kaposi's sarcoma

Journal of Clinical Microbiology

Volumn 39, Issue 12, 2001, Pages 4269-4273

  Tedeschi, R ^a   Enbom, M ^a   Bidoli, E ^a   Linde, A ^a   De Paoli, P ^a   Dillner, J ^a  

^a CENTRO DI RIFERIMENTO ONCOLOGICO   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; CD4 ANTIGEN; VIRUS ANTIGEN; VIRUS DNA; VIRUS RNA;

ADULT; ANTIBODY TITER; ARTICLE; BLOOD; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; HUMAN; HUMAN HERPESVIRUS 8; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOFLUORESCENCE; KAPOSI SARCOMA; LYMPHOCYTE COUNT; MALE; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; TREATMENT OUTCOME; VIREMIA; VIRUS LOAD;

ADULT; AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANTIBODIES, VIRAL; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CD4 LYMPHOCYTE COUNT; DNA, VIRAL; FEMALE; HERPESVIRUS 8, HUMAN; HIV INFECTIONS; HIV-1; HUMANS; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; RNA, VIRAL; SARCOMA, KAPOSI; VIRAL LOAD;

DNA VIRUSES; HERPESVIRIDAE; HERPESVIRUS 8; HUMAN HERPESVIRUS 8; HUMAN IMMUNODEFICIENCY VIRUS;

EID: 0035205595     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/JCM.39.12.4269-4273.2001     Document Type: Article

References (44)

1. Epstein-Barr virus DNA in serum after liver transplantation-surveillance of viral activity during treatment with different immunosuppressive agents
2. Complete histological regression of Kaposi's sarcoma following treatment with protease inhibitors despite persistence of HHV-8 in lesions
3. Human herpesvirus 8 is present in the lymphoid system of healthy persons and can reactivate in the course of AIDS
4. Evaluation of the human herpesvirus 8 DNA load in blood and Kaposi's sarcoma skin lesions from AIDS patients on highly active antiretroviral therapy
5. Kaposi's sarcoma-associated herpesvirus
6. Cytomegalovirus DNA detection in sera from patients with active cytomegalovirus infections
7. Human herpesvirus 8 (Kaposi's sarcoma-associated herpesvirus) infection in men receiving treatment for HIV-1 infection
8. HHV-8 peripheralblood viral load and the titer of antibodies against HHV-8
9. Relationship of human herpesvirus 8 peripheral blood virus load and Kaposi's sarcoma clinical stage
10. Human herpesvirus 8 in Italian HIV-seronegative patients with Kaposi sarcoma
11. Regression of AIDS-related Kaposi's sarcoma following antiretroviral therapy with protease inhibitors: Biological correlates of clinical outcome
12. Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma
13. The Kaposi sarcoma-associated herpesvirus (KSHV) is present as an intact latent genome in KS tissue but replicates in the peripheral blood mononuclear cells of KS patients
14. Antiretroviral therapy with protease inhibitors in human immunodeficiency virus type 1- and human herpesvirus 8-coinfected patients
15. Effects of subcutaneous interleukin-2 therapy on CD4 subsets and in vitro cytokine production in HIV+ subjects
16. Detection of EBV, but not HHV8. DNA in cervical secretions from Swedish women
17. Real time quantitative PCR
18. Reciprocal regulatory interaction between human herpesvirus 8 and human immunodeficiency virus type 1
19. Human herpesvirus 8 and Kaposi's sarcoma-some answers, more questions
20. AIDS-related Kaposi's sarcoma: Prospective validation of the AIDS Clinical Trials Group staging classification
21. Quantitative analysis of human herpesvirus 8 viral load using a realtime PCR assay
22. Effect of human immunodeficiency virus-1 protease inhibitors on the clearance of human herpesvirus 8 from blood of human immunodeficiency virus-l-infected patients
23. Clinical and biological impact of antiretroviral therapy with protease inhibitors on HIV-related Kaposi's sarcoma
24. Antibodies to human herpesvirus type 8 in the general population and in Kaposi's sarcoma patients
25. Long-lasting recovery in CD4 T-cell function and viral-load reduction after highly active antiretroviral therapy in advanced HIV-1 disease
26. Quantitative and temporal correlation between circulating cell-free Epstein-Barr virus DNA and tumor recurrence in nasopharyngeal carcinoma
27. Complete regression of AIDS-related Kaposi's sarcoma-associated human herpesvirus-8 during therapy with indinavir
28. Detection of Kaposi's sarcoma-associated herpesvirus in peripheral blood cells in human immunodeficiency virus infection: Association with Kaposi's sarcoma, CD4 cell count, and HIV RNA levels
29. Kaposi's sarcoma-associated herpesvirus infection prior to onset of Kaposi's sarcoma
30. Clearance of human herpesvirus type 8 viraemia in HIV-1-positive patients with Kaposi's sarcoma treated with liposomal doxorubicin. Caelyx/KS spanish study group
31. Visualization of human herpesvirus type 8 in Kaposi's sarcoma by light and transmission electron microscopy
32. A randomized trial of three maintenance regimens given after three months of induction therapy with zidovudine, lamivudine, and indinavir in previously untreated HIV-1-infected patients
33. Identification of a chemokine receptor encoded by human cytomegalovirus as a cofactor for HIV-1 entry
34. Clearance of HHV-8 from peripheral blood mononuclear cells with a protease inhibitor
35. Epstein-Barr virus nuclear antigen 2 transactivates the long terminal repeat of human immunodeficiency virus type 1
36. KSHV (HHV8) infection
37. Detection of human herpesvirus 6 in plasma of children with primary infection and immunosuppressed patients by polymerase chain reaction
38. Increasing probability of motherto-child transmission of HHV-8 with increasing maternal antibody titer for HHV-8
39. Antibodies against human herpesvirus 8 in black South African patients with cancer
40. Human serum antibodies to a major defined epitope of human herpesvirus 8 small viral capsid antigen
41. Seropositivity to human herpesvirus 8 in relation to sexual history and risk of sexually transmitted infections among women
42. Detection of Kaposi sarcoma associated herpesvirus in peripheral blood of HIV-infected individuals and progression to Kaposi's sarcoma
43. Regression of AIDS-related Kaposi's sarcoma associated with clearance of human herpesvirus-8 from peripheral blood mononuclear cells following initiation of antiretroviral therapy